Publicaciones

66P Impact of MAF selection of patients for adjuvant bisphosphonate therapy and comparison with current clinical guidance. Coleman, R.E. et al.

Leer más sobre "Impact of MAF selection of patients for adjuvant bisphosphonate therapy and comparison with current clinical guidance"

Leer más sobre "Paterson et al. "MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice.""

Leer más sobre "Paterson et al. "Validation of MAF Biomarker for Response Prediction to Adjuvant Bisphosphonates in 2 Clinical Trials: AZURE & NSABP-B34.""

Leer más sobre "Coleman et al. "Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04).""

Leer más sobre "Coleman et al. "Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial.""

Leer más sobre "Pavlovic et al. "Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis.""